research use only

Diquafosol Tetrasodium P2 Receptor agonist

Cat.No.S6592

Diquafosol Tetrasodium (INS-365), a P2Y2 receptor agonist, is a pharmaceutical drug for the treatment of dry eye disease.
Jump to

Quality Control

Batch: Purity: 99.84%
99.84

Solubility

In vitro
Batch:

Water : 100 mg/mL

DMSO : Insoluble
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 878.23 Formula

C18H22N4Na4O23P4

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 211427-08-6 -- Storage of Stock Solutions

Synonyms INS-365 SMILES C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O.[Na+].[Na+].[Na+].[Na+]

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
P2Y2 receptor
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-04-30)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06903884 RECRUITING
Vernal Keratoconjunctivitis
The University of Hong Kong
2026-02-09 PHASE3
NCT07397949 NOT_YET_RECRUITING
Dry Eye Disease (DED); Cataract
Samsung Medical Center
2026-03 PHASE4
NCT06852105 NOT_YET_RECRUITING
Dry Eye; Tear Break-Up Time
He Eye Hospital
2025-02-28
NCT07097922 NOT_YET_RECRUITING
Dry Eye
He Eye Hospital
2025-08-01
NCT07397936 COMPLETED
Dry Eye Disease (DED); Cataract
Samsung Medical Center
2024-08-01 PHASE4
NCT06537349 UNKNOWN
Dry Eye
He Eye Hospital
2024-08-15

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map